Analysts had predicted that Lartruvo could eventually ring up as much as $600 million in annual sales. Eli Lilly and Co. now says it will suspend promotion of the drug.
Now that Bates-Hendricks has emerged as one of the city’s housing hot spots, its neighborhood association is focusing on the commercial boom residents believe will follow.
The Catalyst Award recognizes companies that excel in addressing recruitment, development and advancement of women. Today, nearly half of Lilly's senior leadership is female, up from 20 percent four years ago.
A trio of jocks and computer geeks from Rose-Hulman Institute of Technology has produced computer software that has had a major impact on the top level of college baseball and softball. Now the small, self-funded firm is making a big play in the NFL with data analytics.
A prolonged shutdown could muddle Eli Lilly and Co.’s plan to unload its stake in Elanco Animal Health Inc., the unit it spun off last year, Lilly CEO Dave Ricks said.
Eli Lilly and Co. won’t put the price of its prescription drugs in television ads, as the Trump administration has called for pharmaceutical companies to do, but will begin promoting a website where prices are available.
Drug industry analysts on Monday applauded Eli Lilly and Co.’s pending $8 billion cash deal to buy a startup that focuses on oncology, which has become a prime focus for the pharma giant in the last year.
Connecticut-based Loxo Oncology, which was founded in 2013 and went public a year later, has a cancer drug in development that recently received U.S. Food and Drug Administration "breakthrough therapy" status.
Pharmaceutical giants Merck & Co. and Pfizer Inc. were kings of the Dow Jones industrial index during the year, while Eli Lilly and Co. was among the 20 largest gainers on the S&P 500.
Several well-known Indiana companies were acquisition targets, including biotech firm Endocyte Inc., retailer The Finish Line Inc., racino owner Centaur Gaming, auto body chain Church Brothers Collision Repair, banking company MainSource Financial Group, and gas and electric utility Vectren Corp.
The Greenfield-based company, which staged its initial public offering in September, said the restructuring is intended “to streamline its international operations."
The Indianapolis drugmaker said its 2-year-old anti-inflammatory medicine showed superiority in a head-to-head trial against Humira, the world’s best-selling drug, for treating psoriatic arthritis.
David Johnson, who has led the life science advocacy and investment group for 14 years, will take over full-time leadership of the Central Indiana Corporate Partnership in 2019.
The driving force behind the explosive growth of Salesforce’s Indianapolis-based Marketing Cloud unit stays out of the local spotlight but is internationally renowned in tech circles.
Developers of 16 Tech—a consortium of offices, laboratories, housing and retail space—believe the campus will become a powerful economic engine by fostering collaboration and innovation.
Agricultural and ag-technology firms in Indiana and throughout the Midwest are about to get a major shot of fertilizer from a California accelerator with blue-chip partners that plans to expand here.
At issue in the five-year legal dispute was whether Dr. Rick Sasso was properly compensated for various inventions, and whether Minnesota-based Medtronic paid him sufficient royalties as spelled out in their agreements.
Makers of antidepressants and antipsychotics like Indianapolis-based Eli Lilly and Co., AstraZeneca, Pfizer, Allergan, Bausch Health and Otsuka Holdings might face new challenges and may be deterred from price hikes.
